A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion
- PMID: 11687973
- DOI: 10.1038/sj.onc.1204847
A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion
Abstract
Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not urokinase-type plasminogen activator, tissue plasminogen activator, or thrombin. Preliminary findings in our laboratory suggested that the expression of TFPI-2 is downregulated or lost during tumor progression in human gliomas. To investigate the role of TFPI-2 in the invasiveness of brain tumors, we stably transfected the human high-grade glioma cell line SNB19 and the human low-grade glioma cell line Hs683 with a vector capable of expressing a transcript complementary to the full-length TFPI-2 mRNA in either sense (0.7 kb) or antisense (1 kb) orientations. Parental cells and stably transfected cell lines were analysed for TFPI-2 protein by Western blotting and for TFPI-2 mRNA by Northern blotting. The levels of TFPI-2 protein and mRNA were higher in the sense clones (SNB19) and decreased in the antisense (Hs683) clones than in the corresponding parental and vector controls. In spheroid and matrigel invasion assays, the SNB19 parental cells were highly invasive, but the sense-transfected SNB-19 clones were much less invasive; the antisense-transfected Hs683 clones were more invasive than their parental and vector controls. After intracerebral injection in mice, the sense-transfected SNB19 clones were less able to form tumors than were their parental and vector controls, and the antisense-Hs683 clones but not the parental or vector controls formed small tumors. This is the first study to demonstrate that down- or upregulation of TFPI-2 plays a significant role in the invasive behavior of human gliomas.
Similar articles
-
Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro.Int J Oncol. 2001 Jan;18(1):127-31. Int J Oncol. 2001. PMID: 11115549
-
Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.Clin Cancer Res. 2001 Mar;7(3):570-6. Clin Cancer Res. 2001. PMID: 11297250
-
In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor.Oncogene. 1997 Mar 20;14(11):1351-9. doi: 10.1038/sj.onc.1200963. Oncogene. 1997. PMID: 9178895
-
The role of tissue factor pathway inhibitor-2 in cancer biology.Semin Thromb Hemost. 2007 Oct;33(7):653-9. doi: 10.1055/s-2007-991532. Semin Thromb Hemost. 2007. PMID: 18000791 Review.
-
[Inhibition of cellular adhesion and invasion in gliomas].Nihon Rinsho. 2005 Sep;63 Suppl 9:68-73. Nihon Rinsho. 2005. PMID: 16201502 Review. Japanese. No abstract available.
Cited by
-
TFPI-2 is a putative tumor suppressor gene frequently inactivated by promoter hypermethylation in nasopharyngeal carcinoma.BMC Cancer. 2010 Nov 9;10:617. doi: 10.1186/1471-2407-10-617. BMC Cancer. 2010. PMID: 21062455 Free PMC article.
-
Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.Prog Neurobiol. 2018 Jun-Aug;165-167:26-50. doi: 10.1016/j.pneurobio.2018.01.003. Epub 2018 Jan 31. Prog Neurobiol. 2018. PMID: 29355711 Free PMC article. Review.
-
TFPI2 Promotes Perivascular Migration in an Angiotropism Model of Melanoma.Front Oncol. 2021 Jun 24;11:662434. doi: 10.3389/fonc.2021.662434. eCollection 2021. Front Oncol. 2021. PMID: 34249699 Free PMC article.
-
microRNAs and Markers of Neutrophil Activation as Predictors of Early Incidental Post-Surgical Pulmonary Embolism in Patients with Intracranial Tumors.Cancers (Basel). 2020 Jun 11;12(6):1536. doi: 10.3390/cancers12061536. Cancers (Basel). 2020. PMID: 32545233 Free PMC article.
-
Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion.Clin Exp Metastasis. 2009;26(5):457-67. doi: 10.1007/s10585-009-9245-z. Epub 2009 Mar 7. Clin Exp Metastasis. 2009. PMID: 19267203
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous